Cargando…
Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model
Long-term ad libitum dietary restrictions, such as low-protein diets (LPDs), improve metabolic health and extend the life span of mice and humans. However, most studies conducted thus far have focused on the preventive effects of LPDs on metabolic syndromes. To test the therapeutic potential of LPD,...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081364/ https://www.ncbi.nlm.nih.gov/pubmed/37034803 http://dx.doi.org/10.21203/rs.3.rs-2701883/v1 |
_version_ | 1785021106889949184 |
---|---|
author | Munoz, Marcos Zamudio, Alexa McCann, Maximilian Gil, Victoria Xu, Pingwen Liew, Chong Wee |
author_facet | Munoz, Marcos Zamudio, Alexa McCann, Maximilian Gil, Victoria Xu, Pingwen Liew, Chong Wee |
author_sort | Munoz, Marcos |
collection | PubMed |
description | Long-term ad libitum dietary restrictions, such as low-protein diets (LPDs), improve metabolic health and extend the life span of mice and humans. However, most studies conducted thus far have focused on the preventive effects of LPDs on metabolic syndromes. To test the therapeutic potential of LPD, we treated a lipodystrophy mouse model IR(FKO) (adipose-specific insulin receptor knockout) in this study. We have previously shown that IR(FKO) mice have profound insulin resistance, hyperglycemia, and whitenng of interscapular brown adipose tissue (BAT), closely mimicking the phenotypes in lipoatrophic diabetic patients. Here, we demonstrate that 14-day of LPD (5.1% kcal from protein) feeding is sufficient to reduce postprandial blood glucose, improve insulin resistance, and normalize glucose tolerance in the IR(FKO) mice. This profound metabolic improvement is associated with BAT activation and increase in whole body energy expenditure. To confirm, we showed that surgical denervation of BAT attenuated the beneficial metabolic effects of LPD feeding in IR(FKO) mice, including the ‘browning’ effects on BAT and the glucose-ameliorating results. However, BAT denervation failed to affect the body weight-lowering effects of LPD. Together, our results imply a therapeutic potential to use LPD for the treatment of lipoatrophic diabetes. |
format | Online Article Text |
id | pubmed-10081364 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Journal Experts |
record_format | MEDLINE/PubMed |
spelling | pubmed-100813642023-04-08 Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model Munoz, Marcos Zamudio, Alexa McCann, Maximilian Gil, Victoria Xu, Pingwen Liew, Chong Wee Res Sq Article Long-term ad libitum dietary restrictions, such as low-protein diets (LPDs), improve metabolic health and extend the life span of mice and humans. However, most studies conducted thus far have focused on the preventive effects of LPDs on metabolic syndromes. To test the therapeutic potential of LPD, we treated a lipodystrophy mouse model IR(FKO) (adipose-specific insulin receptor knockout) in this study. We have previously shown that IR(FKO) mice have profound insulin resistance, hyperglycemia, and whitenng of interscapular brown adipose tissue (BAT), closely mimicking the phenotypes in lipoatrophic diabetic patients. Here, we demonstrate that 14-day of LPD (5.1% kcal from protein) feeding is sufficient to reduce postprandial blood glucose, improve insulin resistance, and normalize glucose tolerance in the IR(FKO) mice. This profound metabolic improvement is associated with BAT activation and increase in whole body energy expenditure. To confirm, we showed that surgical denervation of BAT attenuated the beneficial metabolic effects of LPD feeding in IR(FKO) mice, including the ‘browning’ effects on BAT and the glucose-ameliorating results. However, BAT denervation failed to affect the body weight-lowering effects of LPD. Together, our results imply a therapeutic potential to use LPD for the treatment of lipoatrophic diabetes. American Journal Experts 2023-03-31 /pmc/articles/PMC10081364/ /pubmed/37034803 http://dx.doi.org/10.21203/rs.3.rs-2701883/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. https://creativecommons.org/licenses/by/4.0/License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Article Munoz, Marcos Zamudio, Alexa McCann, Maximilian Gil, Victoria Xu, Pingwen Liew, Chong Wee Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model |
title | Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model |
title_full | Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model |
title_fullStr | Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model |
title_full_unstemmed | Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model |
title_short | Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model |
title_sort | activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081364/ https://www.ncbi.nlm.nih.gov/pubmed/37034803 http://dx.doi.org/10.21203/rs.3.rs-2701883/v1 |
work_keys_str_mv | AT munozmarcos activationofbrownadiposetissuebyalowproteindietameliorateshyperglycemiainadiabeticlipodystrophymousemodel AT zamudioalexa activationofbrownadiposetissuebyalowproteindietameliorateshyperglycemiainadiabeticlipodystrophymousemodel AT mccannmaximilian activationofbrownadiposetissuebyalowproteindietameliorateshyperglycemiainadiabeticlipodystrophymousemodel AT gilvictoria activationofbrownadiposetissuebyalowproteindietameliorateshyperglycemiainadiabeticlipodystrophymousemodel AT xupingwen activationofbrownadiposetissuebyalowproteindietameliorateshyperglycemiainadiabeticlipodystrophymousemodel AT liewchongwee activationofbrownadiposetissuebyalowproteindietameliorateshyperglycemiainadiabeticlipodystrophymousemodel |